Cambrex Corp. (CBM) Announces Completion of PharmaCore Acquisition

October 7, 2016 10:36 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Cambrex Corporation (NYSE: CBM) announced that it has completed the acquisition of PharmaCore, Inc., a privately-owned company located in High Point, North Carolina, specializing in developing, manufacturing and scaling up small molecule APIs for clinical phase projects. This completes the transaction initially announced on September 26, 2016. With the acquisition of PharmaCore, which has been renamed Cambrex High Point, Inc., Cambrex enhances its capabilities and expertise to efficiently develop early clinical phase products and new technologies.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Mergers and Acquisitions

Related Entities

Earnings, Definitive Agreement

Add Your Comment